ECDC issues guidance on scaling up capability and capacity to characterise SARS-CoV-2 variants

by

in

New SARS-CoV-2 variants of interest and concern have continued to emerge in the first few months of 2022 and monitoring their circulation in all countries through genomic surveillance remains important.